Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review

被引:44
作者
Mosheimer, Birgit A. [1 ]
Oppl, Bastian [2 ,3 ]
Zandieh, Shahin [4 ]
Fillitz, Michael [5 ]
Keil, Felix [5 ]
Klaushofer, Klaus [2 ,3 ]
Weiss, Guenter [1 ]
Zwerina, Jochen [2 ,3 ]
机构
[1] Med Univ Innsbruck, Dept Internal Med 4, Infect Dis Immunol Rheumatol Pneumol, Anichstr 35, Innsbruck, Austria
[2] Hanusch Hosp WGKK, Ludwig Boltzmann Inst Osteol, Vienna, Austria
[3] Hanusch Hosp, AUVA Trauma Ctr Meidling, Med Dept 1, Vienna, Austria
[4] Hanusch Hosp, Inst Radiol & Nucl Med, Vienna, Austria
[5] Hanusch Hosp, Med Dept 3, Vienna, Austria
关键词
Rosai-Dorfman disease; Bone involvement; Treatment strategies; LANGERHANS CELL HISTIOCYTOSIS; ERDHEIM-CHESTER-DISEASE; MASSIVE LYMPHADENOPATHY; SINUS HISTIOCYTOSIS; ASSOCIATION; DISORDERS;
D O I
10.1007/s11926-017-0656-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Rosai-Dorfman disease (RDD) is a rare histiocytic disorder typically presenting as painless cervical lymphadenopathy. Extranodal involvement is common and may also affect bones. Here, we present a patient with typical nodal disease and multifocal bone manifestations. Further, a systematic literature review was performed to better understand the phenotype, clinical course and treatment options of such patients. Recent Findings RDD is a nonmalignant, classically sporadic histiocytosis. Nevertheless, increasing evidence also suggests familial forms of the disease. According to our literature review, bone involvement is exceedingly rare and heterogeneous. Clinical outcome in terms of mortality seems to be favorable in most cases. Currently, therapy strategies include surgical and immunosuppressive treatments, but the optimal treatment of osseous RDD remains to be defined. Summary Patients with osseous RDD may present to rheumatologists with arthralgia or arthritis. Due to the rarity of the disease, diagnosis and treatment remain challenging.
引用
收藏
页数:5
相关论文
共 18 条
  • [1] Potential clinical implications of BRAF mutations in histiocytic proliferations
    Bubolz, Anna-Maria
    Weissinger, Stephanie E.
    Stenzinger, Albrecht
    Arndt, Annette
    Steinestel, Konrad
    Bruederlein, Silke
    Cario, Holger
    Lubatschofski, Anneli
    Welke, Claudia
    Anagnostopoulos, Ioannis
    Barth, Thomas F. E.
    Beer, Ambros J.
    Moeller, Peter
    Gottstein, Martin
    Viardot, Andreas
    Lennerz, Jochen K.
    [J]. ONCOTARGET, 2014, 5 (12) : 4060 - 4070
  • [2] Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment
    Dalia, Samir
    Sagatys, Elizabeth
    Sokol, Lubomir
    Kubal, Timothy
    [J]. CANCER CONTROL, 2014, 21 (04) : 322 - 327
  • [3] Primary Rosai-Dorfman Disease of Bone A Clinicopathologic Study of 15 Cases
    Demicco, Elizabeth G.
    Rosenberg, Andrew E.
    Bjornsson, Johannes
    Rybak, Leon D.
    Unni, K. Krishnan
    Nielsen, G. Petur
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (09) : 1324 - 1333
  • [4] Emile JF, 2016, BLOOD
  • [5] FOUCAR E, 1990, SEMIN DIAGN PATHOL, V7, P19
  • [6] Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
    Hervier, Baptiste
    Haroche, Julien
    Arnaud, Laurent
    Charlotte, Frederic
    Donadieu, Jean
    Neel, Antoine
    Lifermann, Francois
    Villabona, Carles
    Graffin, Bruno
    Hermine, Olivier
    Rigolet, Aude
    Roubille, Camille
    Hachulla, Eric
    Carmoi, Thierry
    Bezier, Maud
    Meignin, Veronique
    Conrad, Marie
    Marie, Laurence
    Kostrzewa, Elise
    Michot, Jean-Marie
    Barete, Stephane
    Taly, Valerie
    Cury, Karine
    Emile, Jean-Francois
    Amoura, Zahir
    [J]. BLOOD, 2014, 124 (07) : 1119 - 1126
  • [7] Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease
    Inoue, S
    Onwuzurike, N
    [J]. PEDIATRIC BLOOD & CANCER, 2005, 45 (01) : 84 - 85
  • [8] Erdheim-Chester disease: Evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis
    Kenn, W
    Eck, M
    Allolio, B
    Jakob, F
    Illg, A
    Marx, A
    Mueller-Hermelink, HK
    Hahn, D
    [J]. HUMAN PATHOLOGY, 2000, 31 (06) : 734 - 739
  • [9] McClain Kenneth L, 2004, Hematology Am Soc Hematol Educ Program, P283
  • [10] A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?
    Menon, Madhu P.
    Evbuomwan, Moses O.
    Rosai, Juan
    Jaffe, Elaine S.
    Pittaluga, Stefania
    [J]. HISTOPATHOLOGY, 2014, 64 (03) : 455 - 459